Stock Screener App

무료 -

12.77

2.82% +0.35

Mineralys Therapeutics Inc (MLYS)

개요 뉴스 가격 이력 옵션 체인 Financials 토론 예측

Mineralys Therapeutics Inc 주식(MLYS)의 최신 뉴스

Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Shares Purchased by Franklin Resources Inc. - MarketBeat

Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Shares Sold by Jump Financial LLC - Defense World

Russell Investments Group Ltd. Reduces Position in Mineralys Therapeutics, Inc. (NASDAQ:MLYS) - Defense World

Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Q1 2024 Earnings Call Transcript - Insider Monkey

Earnings call: Mineralys highlights progress in lorundrostat hypertension trials - Investing.com Canada

Investing.com Canada

Earnings call: Mineralys highlights progress in lorundrostat hypertension trials By Investing.com - Investing.com

Earnings call: Mineralys highlights progress in lorundrostat hypertension trials - Investing.com India

Investing.com India

Earnings call: Mineralys highlights progress in lorundrostat hypertension trials By Investing.com - Investing.com UK

Investing.com UK

Mineralys Therapeutics : Corporate Overview May 2024 - Marketscreener.com

Marketscreener.com

Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Q1 2024 Earnings Call Transcript - Insider Monkey

We Think Mineralys Therapeutics (NASDAQ:MLYS) Can Afford To Drive Business Growth - Yahoo Finance

Earnings call: Mineralys highlights progress in lorundrostat hypertension trials By Investing.com - Investing.com

How the (MLYS) price action is used to our Advantage - Stock Traders Daily

Stock Traders Daily

Mineralys Therapeutics Reports Robust Financial Results for Q1 2024 - MSN

Mineralys Therapeutics Reports Robust Financial Results for Q1 2024 - MSN

Mineralys Therapeutics Reports Robust Financial Results for Q1 2024 - MyChesCo

Mineralys Therapeutics CMO sells shares worth $1500 By Investing.com - Investing.com

Mineralys Therapeutics Reports Robust Financial Results for Q1 2024 - MyChesCo

Mineralys Therapeutics (NASDAQ:MLYS) Stock Price Down 4.6% - MarketBeat

Cwm LLC Purchases 3213 Shares of Mineralys Therapeutics, Inc. (NASDAQ:MLYS) - Defense World

Mineralys Therapeutics CMO sells shares worth $1500 By Investing.com - Investing.com

Mineralys Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewswire

Mineralys Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewswire

Mineralys Therapeutics to Participate in the Bank of America Securities Health Care Conference - Yahoo Finance

Federated Hermes Inc. Sells 2261 Shares of Mineralys Therapeutics, Inc. (NASDAQ:MLYS) - Defense World

Federated Hermes Inc. Sells 2261 Shares of Mineralys Therapeutics, Inc. (NASDAQ:MLYS) - Defense World

Mineralys Therapeutics to Unveil First Quarter Financial Results - MyChesCo

(MLYS) Long Term Investment Analysis - Stock Traders Daily

Stock Traders Daily

Mineralys Therapeutics to Announce First Quarter 2024 Financial Results and Host Conference Call on Thursday, May ... - Yahoo Finance

Mineralys Therapeutics to Announce First Quarter 2024 Financial Results and Host Conference Call on Thursday, May ... - Yahoo Finance

Mineralys Therapeutics Breaks Below 200-Day Moving Average - Notable for MLYS - Nasdaq

Windtree Therapeutics Announces Reverse Stock Split in Strategy to Boost Market Compliance - MyChesCo

Mineralys Therapeutics Board Member Announces Departure - TipRanks.com - TipRanks

Mineralys Therapeutics board member to exit at term end - Investing.com

Goldman ups Mineralys Therapeutics shares target, sees hypertension treatment potential - Investing.com

Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Q4 2023 Earnings Call Transcript - Yahoo Finance

Mineralys Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update - GlobeNewswire

Mineralys Therapeutics: A Story To Keep An Eye On (NASDAQ:MLYS) - Seeking Alpha

Mineralys Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call on Thursday, March 21, 2024

GlobeNewswire Inc.

Mineralys Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call ... - Yahoo Finance

Aclaris Therapeutics: A Year of Financial Resilience and Steady Advancements - MyChesCo

Mineralys Therapeutics Secures $120M in Private Placement - TipRanks

Mineralys Therapeutics set to raise $120M from investors - Philadelphia Business Journal - The Business Journals

The Business Journals

Why Compass Minerals International Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Arm Holdings Posts Upbeat Results, Joins Hershey, CyberArk Software, Wynn Resorts And Other Big Stocks Moving Higher On Thursday

Mineralys Therapeutics Announces $120 Million Private Placement Financing - GlobeNewswire

Mineralys Therapeutics to Participate in the Guggenheim Securities 6th Annual Biotechnology Conference

GlobeNewswire Inc.

Mineralys Therapeutics, Inc. (MLYS) Upgraded to Strong Buy: Here's What You Should Know

Zacks Investment Research

Mineralys Therapeutics Appoints Minji Kim, Ph.D. as Chief Business Officer

GlobeNewswire Inc.

Mineralys Therapeutics Appoints Minji Kim, Ph.D. as Chief Business Officer - GlobeNewswire

$75.07

0.79%

$148.85

3.50%

$28.20

0.75%

$148.43

1.07%

$371.02

2.45%

$100.60

1.87%

야후에서 열기 | 구글에서 열기 | 핀비즈에서 열기